Search Results

Biotech venture capital firm Flagship Pioneering is looking to fund companies focused on artificial intelligence, human health and sustainability, bringing the total raised since 2021 to $6.4 billion.

Bluejay Diagnostics, Inc., announced results from the primary analysis of SYMON-I, a multicenter pilot clinical study investigating the role of interleukin-6 in patients diagnosed with sepsis and septic shock.

AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

Assembly Biosciences, Inc. today announced that it has closed the issuance of shares of its common stock and warrants to Armistice Capital LLC (“Armistice Capital”), a healthcare-focused institutional investor, and Gilead Sciences, Inc. (“Gilead”), in separate equity financings that have resulted in aggregate gross proceeds to Assembly Bio of approximately $12.6 million, before deducting expenses.

Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap Rodeo Conference, that will be held on Thursday, June 6, 2024 in New York City.

Palatin Technologies, Inc. today announced that it has entered into a warrant inducement agreement with an institutional investor to exercise certain outstanding warrants that the Company issued in November 2022 and October 2023 totaling 3,233,277 shares of the Company’s common stock for gross proceeds of approximately $6.1 million.

CDR-Life Inc. today announced that Chief Medical Officer Swethajit Biswas, MD, FRCP, will co-lead a seminar at the 6th Annual Cell Engager Summit, occurring May 21-23 in Boston.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced its participation in the Jefferies Healthcare Conference in New York on June 5-6, 2024.

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced that it will be participating in the Spring MicroCap Rodeo Conference that will be held on Thursday, June 6, 2024 in New York City.

Polarean Imaging plc, a commercial-stage medical device leader in advanced Magnetic Resonance Imaging of the lungs, announces the closing of a $12.6 million oversubscribed financing via the Alternative Investment Market of the London Stock Exchange.